Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Predicting MYCN amplification in paediatric neuroblastoma: development and validation of a 18F-FDG PET/CT-based radiomics signature ; volume:14 ; number:1 ; day:24 ; month:11 ; year:2023 ; pages:1-12 ; date:12.2023
Insights into imaging ; 14, Heft 1 (24.11.2023), 1-12, 12.2023
- Urheber
-
Qian, Luo-Dan
Zhang, Shu-Xin
Li, Si-Qi
Feng, Li-Juan
Zhou, Zi-Ang
Liu, Jun
Zhang, Ming-Yu
Yang, Ji-Gang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13244-023-01493-8
- URN
-
urn:nbn:de:101:1-2024020714412697832588
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Qian, Luo-Dan
- Zhang, Shu-Xin
- Li, Si-Qi
- Feng, Li-Juan
- Zhou, Zi-Ang
- Liu, Jun
- Zhang, Ming-Yu
- Yang, Ji-Gang
- SpringerLink (Online service)
Ähnliche Objekte (12)
MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples
MYCN modulates the restriction point and ferroptosis in Neuroblastoma
MYCN modulates the restriction point and ferroptosis in Neuroblastoma
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status
Genetic alterations and resectability predict outcome in patients with neuroblastoma assigned to high-risk solely by MYCN amplification
MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples
MYCN modulates the restriction point and ferroptosis in Neuroblastoma
MYCN modulates the restriction point and ferroptosis in Neuroblastoma
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status
Genetic alterations and resectability predict outcome in patients with neuroblastoma assigned to high-risk solely by MYCN amplification
MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples
MYCN modulates the restriction point and ferroptosis in Neuroblastoma
MYCN modulates the restriction point and ferroptosis in Neuroblastoma
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and MYCN amplification status